Evidence mapPaperPMID 34575255Full record

ReviewJournal of clinical medicine2021

Potentially Detrimental Effects of Hyperosmolality in Patients Treated for Traumatic Brain Injury.

Wojciech Dabrowski, Dorota Siwicka-Gieroba, Chiara Robba, Magdalena Bielacz, Joanna Sołek-Pastuszka, Katarzyna Kotfis, Romuald Bohatyrewicz, Andrzej Jaroszyński, Manu L N G Malbrain, Rafael Badenes

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Mobilization in Neurocritical Care: Challenges and Opportunities.Current neurology and neuroscience reports · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Wojciech DabrowskiDepartment of Anaesthesiology and Intensive Care, Medical University of Lublin, 20-954 Lublin, Poland.ORCID 0000-0003-0449-2375
Dorota Siwicka-GierobaDepartment of Anaesthesiology and Intensive Care, Medical University of Lublin, 20-954 Lublin, Poland.ORCID 0000-0002-1001-0080
Chiara RobbaDepartment of Anaesthesia and Intensive Care, Policlinico San Martino, 16100 Genova, Italy.
Magdalena BielaczInstitute of Tourism and Recreation, State Vocational College of Szymon Szymonowicz, 22-400 Zamosc, Poland.
Joanna Sołek-PastuszkaDepartment of Anaesthesiology and Intensive Care, Pomeranian Medical University, 71-252 Szczecin, Poland.
Katarzyna KotfisDepartment of Anaesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University, 70-111 Szczecin, Poland.ORCID 0000-0001-8430-1369
Romuald BohatyrewiczDepartment of Anaesthesiology and Intensive Care, Pomeranian Medical University, 71-252 Szczecin, Poland.ORCID 0000-0003-1914-826X
Andrzej JaroszyńskiDepartment of Nephrology, Institute of Medical Science, Jan Kochanowski University of Kielce, 25-736 Kielce, Poland.
Manu L N G MalbrainDepartment of Anaesthesiology and Intensive Care, Medical University of Lublin, 20-954 Lublin, Poland.ORCID 0000-0002-1816-5255
Rafael BadenesDepartment of Anaesthesiology and Intensive Care, Hospital Clìnico Universitario de Valencia, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0001-7017-0150
Medical University of Lublin · PLPomeranian Medical University · PLJan Kochanowski University · PLOspedale Policlinico San Martino · ITState Higher School of Vocational Education in Zamość · PLUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperosmotic therapy is commonly used to treat intracranial hypertension in traumatic brain injury patients. Unfortunately, hyperosmolality also affects other organs. An increase in plasma osmolality may impair kidney, cardiac, and immune function, and increase blood-brain barrier permeability. These effects are related not only to the type of hyperosmotic agents, but also to the level of hyperosmolality. The commonly recommended osmolality of 320 mOsm/kg H

Indexed as

hypertonic salinemannitolosmolalityosmolar gaptraumatic brain injury (TBI)

Identifiers

PMID34575255
PMCPMC8467376
OpenAlexW3199926573

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.